-
Full Article (HTML) (113) -
Full Article (PDF) (34) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4466)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2019 (publication date) through Oct 26, 2021
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang MW, Fu XL, Jiang YS, Chen XJ, Tao LY, Yang JY, Huo YM, Liu W, Zhang JF, Liu PF, Liu Q, Hua R, Zhang ZG, Sun YW, Liu DJ. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas. World J Gastroenterol 2019; 25(14): 1684-1696 [PMID: 31011254 DOI: 10.3748/wjg.v25.i14.1684] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i14/1684.htm |
| Number | Citing Articles |
| 1 |
Guanghui Xu, Yuhao Wang, Hushan Zhang, Xueke She, Jianjun Yang. Immunotherapy and potential predictive biomarkers in the treatment of neuroendocrine neoplasia. Future Oncology 2021; 17(9): 1069 doi: 10.2217/fon-2020-0703
|
| 2 |
Mengyuan Liu, Elizabeta C. Popa, Brendan M. Finnerty, Thomas J. Fahey, Rasa Zarnegar. Clinicopathological Features of Gastroesophageal Neuroendocrine Neoplasms. Current Gastroenterology Reports 2020; 22(10) doi: 10.1007/s11894-020-00788-w
|
| 3 |
Caroline Lum, Sophia Frentzas. Research and Clinical Applications of Targeting Gastric Neoplasms. 2021; : 317 doi: 10.1016/B978-0-323-85563-1.00010-1
|
| 4 |
Chunyan Hu, Shu Tian, Lan Lin, Jiahao Zhang, Hao Ding. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma. Oral Oncology 2020; 102: 104560 doi: 10.1016/j.oraloncology.2019.104560
|
| 5 |
Alexander W. MacFarlane, Ho-Man Yeung, R. Katherine Alpaugh, Essel Dulaimi, Paul F. Engstrom, Arvind Dasari, Kerry S. Campbell, Namrata Vijayvergia. Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms. Cancer Immunology, Immunotherapy 2021; 70(7): 1893 doi: 10.1007/s00262-020-02811-5
|
| 6 |
Z. Liu, F. Mi, M. Han, M. Tian, L. Deng, N. Meng, J. Luo, R. Fu.
Bone marrow‐derived mesenchymal stem cells inhibit CD8
+
T cell immune responses via PD‐1/PD‐L1 pathway in multiple myeloma
. Clinical & Experimental Immunology 2021; 205(1): 53 doi: 10.1111/cei.13594
|
| 7 |
Wei Liu, Lei Zhang, Zhiming Xiu, Jian Guo, Liye Wang, Yue Zhou, Yang Jiao, Meiyan Sun, Jianhui Cai. <p>Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer</p>. OncoTargets and Therapy 2020; : 7229 doi: 10.2147/OTT.S255491
|
| 8 |
Anja Rinke, Christoph J Auernhammer, Lisa Bodei, Mark Kidd, Sebastian Krug, Rita Lawlor, Ilaria Marinoni, Aurel Perren, Aldo Scarpa, Halfdan Sorbye, Marianne Ellen Pavel, Matthias M Weber, Irvin Modlin, Thomas M Gress. Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?. Gut 2021; 70(9): 1768 doi: 10.1136/gutjnl-2020-321300
|
| 9 |
Jiazhang Xing, Hongyan Ying, Ji Li, Yang Gao, Zhao Sun, Jiarui Li, Chunmei Bai, Yuejuan Cheng, Huanwen Wu. Immune Checkpoint Markers in Neuroendocrine Carcinoma of the Digestive System. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00132
|
| 10 |
Ilaria Maggio, Lisa Manuzzi, Giuseppe Lamberti, Angela Dalia Ricci, Nastassja Tober, Davide Campana. Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia. Cancers 2020; 12(4): 832 doi: 10.3390/cancers12040832
|
| 11 |
Satoshi Yamashita, Hiroyuki Abe, Akiko Kunita, Hiroharu Yamashita, Yasuyuki Seto, Tetsuo Ushiku. Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma. Histopathology 2021; 78(3): 381 doi: 10.1111/his.14230
|
| 12 |
Virginia Corbett, Susanne Arnold, Lowell Anthony, Aman Chauhan. Management of Large Cell Neuroendocrine Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.653162
|